Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.335 CAD | -1.47% | -4.29% | -14.10% |
Mar. 27 | Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call | |
Mar. 14 | Microbix Says Clot-Buster Drug Project Advancing | MT |
Chart calendar Microbix Biosystems Inc.
Upcoming events on Microbix Biosystems Inc.
Past events on Microbix Biosystems Inc.
2024-04-16 10:30 am | Bloom Burton & Co. Healthcare Investor Conference |
2024-03-27 01:00 pm | Annual General Meeting |
2024-03-12 | EUROGIN International Multidisciplinary HPV Congress |
2024-02-14 10:00 am | Q1 2024 Earnings Call |
2024-02-14 07:13 am | Q1 2024 Earnings Release |
2024-01-03 11:00 am | Q4 2023 Earnings Call |
2023-12-21 07:32 am | Q4 2023 Earnings Release |
2023-11-17 10:00 am | JW Marriott Turnberry Florida Capital Conference |
2023-11-17 10:00 am | Business Update Call |
2023-09-28 | Muskoka Capital Conference |
2023-09-06 01:00 pm | Planet MicroCap Showcase |
2023-08-14 11:00 am | Q3 2023 Earnings Call |
2023-08-10 07:57 am | Q3 2023 Earnings Release |
2023-07-22 | American Association of Clinical Chemistry Conference |
2023-06-14 | American Society of Microbiology Conference |
2023-05-16 11:00 am | Q2 2023 Earnings Call |
2023-05-11 07:30 am | Q2 2023 Earnings Release |
2023-04-26 11:30 am | Bloom Burton & Co Healthcare Investor Conference |
2023-03-29 01:00 pm | Annual General Meeting |
2023-02-14 11:00 am | Q1 2023 Earnings Call |
Annual results
Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 8,27 9,49 -12.77% | 14,5 15,3 -5.31% | 14,0 15,3 -8.42% | 12,4 12,7 -2.22% | 18,6 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -0,70 1,73 -140.53% | 4,41 4,50 -2.2% | 2,68 3,09 -13.47% | -1,18 -0,45 -165.53% | 3,03 |
EBIT | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 2,52 3,06 -17.71% | 1,37 2,16 -36.48% | 0,00 0,00 - | 0,00 |
Net income Million USD | Released Forecast Spread | 0,02 | 0,00 0,00 - | 2,52 3,06 -17.79% | 1,31 2,18 -39.88% | 0,00 0,00 - | 0,00 |
EPS CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,03 0,03 0% | 0,01 0,02 -35% | 0,00 -0,02 - | 0,02 |
Announcement Date | 20/12/19 | 18/12/20 | 23/12/21 | 22/12/22 | 21/12/23 | - |
Quarterly results
Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 3,83 3,97 -3.53% | 3,75 4,68 -19.84% | 3,93 4,26 -7.88% | 3,18 4,02 -20.85% | 1,86 2,85 -34.68% | 3,13 3,07 1.92% | 4,13 3,56 16.08% | 3,21 3,57 -10.05% | 6,20 6,07 2.26% | 3,76 | 3,98 | 4,57 |
EBITDA Million USD | Released Forecast Spread | 1,06 1,18 -9.91% | 0,92 1,74 -47.14% | 0,84 0,68 23.34% | 0,03 0,62 -95.92% | -0,72 0,23 -413.79% | 0,32 -0,15 310.28% | -0,27 0,22 -221.82% | -0,51 0,22 -329.11% | 2,18 2,62 -16.9% | 0,07 | 0,22 | 0,52 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,70 0,85 -17.98% | 0,56 1,39 -59.55% | 0,50 0,44 14.98% | -0,97 0,56 -271.85% | 0,02 0,64 -96.31% | |||||||
Net income Million USD | Released Forecast Spread | 0,70 0,85 -18.12% | 0,56 1,40 -59.78% | 0,50 0,44 13.93% | -0,97 0,57 -270% | 0,02 0,64 -96.34% | |||||||
EPS CAD | Released Forecast Spread | 0,01 0,01 -40% | 0,01 0,01 -58.33% | 0,00 0,00 0% | 0,00 0,01 -160% | -0,01 -0,01 -28.57% | 0,00 0,00 - | -0,01 0,00 - | 0,01 0,00 1500% | ||||
Announcement Date | 10/02/22 | 12/05/22 | 11/08/22 | 22/12/22 | 09/02/23 | 11/05/23 | 10/08/23 | 21/12/23 | 14/02/24 | - | - | - |
Past sector events for Microbix Biosystems Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MBX Stock
- Calendar Microbix Biosystems Inc.